Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

Meeting the needs of the elderly, unfit CLL patient

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 19.12.13
Views: 3784
Rating:

Prof Peter Hillmen - The Leeds Teaching Hospitals NHS Trust, Leeds, UK

Talking to ecancer from the 55th meeting of the American Society of Haematology ( ASH ) in New Orleans, USA, Prof Peter Hillmen, The Leeds Teaching Hospitals NHS Trust, Leeds, UK, outlines the importance of considering co-morbidities in older patients with CLL.  He reviews how current treatments can best be used in this patient cohort, and advises on their main limitations.  Prof Hillmen also notes how clinicians should manage relapsed elderly patients.

Finally, Prof Hillmen outlines his highlights from ASH 2013, such as the trials of chlorambucil in combination with antibodies – and notes his excitement of the recent advances that have been made in CLL.

Read our our ASH 2013 conference report for free. 

This programme has been supported by an unrestricted educational grant from Janssen Pharmaceutica (A Johnson & Johnson Company).

Related videos

follow us

Neutropenia


Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation